- Home
- FCNCP vs SRPT Comparison
FCNCP vs SRPT Comparison
Compare FCNCP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCNCP
- SRPT
- Stock Information
- Founded
- FCNCP N/A
- SRPT 1980
- Country
- FCNCP United States
- SRPT United States
- Employees
- FCNCP 17475
- SRPT N/A
- Industry
- FCNCP Major Banks
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- FCNCP Finance
- SRPT Health Care
- Exchange
- FCNCP Nasdaq
- SRPT Nasdaq
- Market Cap
- FCNCP N/A
- SRPT 2.0B
- IPO Year
- FCNCP N/A
- SRPT 1997
- Fundamental
- Price
- FCNCP $21.70
- SRPT $18.10
- Analyst Decision
- FCNCP
- SRPT Hold
- Analyst Count
- FCNCP 0
- SRPT 31
- Target Price
- FCNCP N/A
- SRPT $40.61
- AVG Volume (30 Days)
- FCNCP N/A
- SRPT 7.8M
- Earning Date
- FCNCP N/A
- SRPT 11-05-2025
- Dividend Yield
- FCNCP N/A
- SRPT N/A
- EPS Growth
- FCNCP N/A
- SRPT N/A
- EPS
- FCNCP N/A
- SRPT N/A
- Revenue
- FCNCP N/A
- SRPT $2,481,531,000.00
- Revenue This Year
- FCNCP N/A
- SRPT $10.78
- Revenue Next Year
- FCNCP N/A
- SRPT N/A
- P/E Ratio
- FCNCP N/A
- SRPT N/A
- Revenue Growth
- FCNCP N/A
- SRPT 64.89
- 52 Week Low
- FCNCP N/A
- SRPT $10.42
- 52 Week High
- FCNCP N/A
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- FCNCP 46.71
- SRPT 51.18
- Support Level
- FCNCP $21.56
- SRPT N/A
- Resistance Level
- FCNCP $21.94
- SRPT $18.21
- Average True Range (ATR)
- FCNCP 0.30
- SRPT 0.88
- MACD
- FCNCP -0.06
- SRPT -0.71
- Stochastic Oscillator
- FCNCP 43.75
- SRPT 92.30
About FCNCP First Citizens BancShares Inc.
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.